Table 5.
Clinical and endovascular factors associated with favorable outcome.
| aOR (95% CI) | p-Value | |
|---|---|---|
| Age | 0.97 (0.94–0.99) | 0.048 * |
| Men | 2.31 (1.09–4.93) | 0.030 * |
| Hypertension | 0.60 (0.25–1.43) | 0.246 |
| Diabetes | 0.34 (0.15–0.81) | 0.014 * |
| Dyslipidemia | 3.17 (1.34–7.48) | 0.009 ** |
| Initial NIHSS score | 0.85 (0.79–0.91) | <0.001 *** |
| Intravenous tPA administration | 2.28 (1.08–4.82) | 0.031 * |
| Successful recanalization | 16.3 (1.62–163.1) | 0.018 * |
| First-pass effect | 3.05 (1.17–7.94) | 0.023 * |
| Number of thrombectomy device passes | 1.14 (0.82–1.57) | 0.440 |
| Preprocedural D-dimer level (per 500 ng/mL) | 0.88 (0.81–0.97) | 0.008 ** |
* p-value < 0.05; ** p-value < 0.01; *** p-value < 0.001. aOR, adjusted odds ratio; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; tPA, tissue-type plasminogen activator.